FORS MARSH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH SERA PROGNOSTICS streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Serán Bioscience Announces Investment by Vivo Capital
A majority investment by Vivo Capital, a healthcare investment firm headquartered in Silicon Valley, will fund the expansion of Serán s service offering, the doubling of clean room capacity by year-end, and the development and construction a new commercial scale cGMP manufacturing facility by the end of 2022.
News provided by
Share this article
Share this article
BEND, Ore., Jan. 6, 2021 /PRNewswire/ Serán Bioscience today announced that healthcare investment firm Vivo Capital has made a majority investment in Serán alongside Serán s founders who will continue to lead the Company.
Founded in 2016, Serán is a leading contract development and manufacturing organization providing a comprehensive suite of development, analytical and clinical manufacturing services to pharmaceutical and biotechnology companies. Serán s deep experience and expertise in materials science, formulation development, engineering, and phar